Polycystic Ovary Syndrome Has Been Renamed
The condition now has a name reflecting its full-body metabolic nature for the one in 10 women it affects.
Updated on Sept. 22, 2026 in Women’s Health
Live Poll
Do you feel confident that updated medical terminology helps doctors better identify and treat your symptoms?
An international panel has renamed polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome to better reflect the condition's impact on the entire body. The syndrome, which affects one in 10 women in the United States, is frequently underdiagnosed.
Why it matters
The change aims to increase clinical awareness of the condition, which is linked to insulin resistance, obesity, type 2 diabetes, fatty liver disease, and cardiovascular disease. Experts hope the new name helps address the estimated 50% of cases that remain undiagnosed.
An international panel of researchers and advocates reached a formal consensus to reclassify the condition. The renaming is based on the prevalence of the disorder in one in 10 women, with half of all cases currently believed to be undiagnosed.
The details
The new name, polyendocrine metabolic ovarian syndrome, integrates endocrine and metabolic features into the diagnostic description. This reflects the condition's systemic nature, where hormonal imbalances and elevated androgen levels—which trigger acne and hair changes—are intertwined with metabolic issues like insulin resistance. The condition also commonly causes irregular periods, ovarian cysts, and infertility.
Timeline
September 22, 2026: The official name change was announced.
Health Landscape
This renaming initiative updates medical terminology to align with the International PCOS Guideline development process. It shifts the clinical focus from isolated ovarian features toward the systemic metabolic and endocrine risks that define the modern understanding of the condition.
If you experience symptoms like irregular periods or androgen-related changes, consider discussing these metabolic links with your doctor. Being aware that this is a systemic condition can help guide a more comprehensive diagnostic conversation during your next checkup.
The takeaway
The move to rename the condition acknowledges that it is a systemic metabolic disorder rather than a purely reproductive one. Tracking your menstrual cycles and discussing metabolic risk factors with your physician are important steps in managing your health.
Further reading
Learn more about managing hormonal and metabolic health in the Women’s Health section.
More information
To find local care or coordinate a clinical appointment, visit the LVHN appointment request portal.
Source note: This article includes information reported by TNonline.
Live Poll
Do you feel confident that updated medical terminology helps doctors better identify and treat your symptoms?
